Warren Cresswell
M.B.A. from the University of Pittsburgh and B.A. in Chemistry from California State University, Northridge. Warren has over 25 years of experience in the diagnostics industry. He was previously CEO at Prometheus Labs, CEO at Microbiome Diagnostic Partners, and Vice President at Dako, leading the Asia Pacific Business Unit.
Current assignments: Board member at Demeter Sciences.
Holdings: 100,000 stock options
Some of our Collaborations
>3200
Numbers of patients in studies
24
Publications
10
Pharma Contracts